US Broker Ratings

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unveiling a 64% Potential Upside in the Rare Disease Market

Eton Pharmaceuticals, Inc. (ETON) is carving a niche within the healthcare sector, specifically in the specialty and generic drug manufacturing industry. With a focus on developing..

Evolus, Inc. (EOLS): Investor Outlook Reveals a Promising 180% Upside Potential

Investors keeping an eye on the healthcare sector might want to consider Evolus, Inc. (EOLS), a company that stands out in the specialty and generic drug..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring an 85% Potential Upside in Biotech Innovation

Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the biotechnology sector with its pioneering approach to drug discovery. Based in Cambridge, Massachusetts, this clinical-stage precision..

Beta Bionics, Inc. (BBNX): Investor Outlook Reveals Impressive Revenue Growth and Analyst Confidence

Beta Bionics, Inc. (NASDAQ: BBNX), a pioneering entity in the healthcare sector, particularly within the medical devices industry, is making significant strides with its innovative solutions..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Unpacking Growth Potential Amid a 12.19% Upside

Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector, operates within the diagnostics and research industry, providing cutting-edge clinical diagnostic and therapeutic development..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A 57.95% Upside Potential Fuels Investor Optimism

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a clinical-stage biopharmaceutical company based in Menlo Park, California, is emerging as a compelling opportunity for investors in the healthcare sector...

Maravai LifeSciences Holdings (MRVI): Investor Outlook Reveals 27% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a name that individual investors might want to keep on their radar, especially considering its intriguing 27.39% potential upside..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: A Biotech Gem with Over 100% Potential Upside

Tyra Biosciences, Inc. (NASDAQ: TYRA) is catching the eye of investors looking for promising opportunities in the biotechnology sector. With a market cap of $835.7 million,..

Akso Health Group (AHG): Investor Outlook on a Rapidly Growing Chinese Medical Distributor

Akso Health Group (NASDAQ: AHG), a prominent player in China’s healthcare sector, is capturing attention due to its staggering revenue growth. Even amidst the complexities of..

Bicycle Therapeutics plc (BCYC) Stock Analysis: High Potential Upside with Promising Pipeline

Bicycle Therapeutics plc (BCYC), a UK-based biotechnology innovator, is catching the attention of investors with its groundbreaking approach to developing novel therapies for underserved diseases. Despite..

Geron Corporation (GERN) Stock Analysis: Exploring a Potential 192% Upside for Healthcare Investors

Geron Corporation (NASDAQ: GERN), a notable player in the biopharmaceutical landscape, presents intriguing opportunities for investors looking to engage in the dynamic healthcare sector. With a..

MBX Biosciences, Inc. (MBX) Stock Analysis: Potential 170.77% Upside in Biotech Sector

Investors seeking opportunities in the biotechnology sector should keep a close eye on MBX Biosciences, Inc. (MBX). This clinical-stage biopharmaceutical company, headquartered in Carmel, Indiana, focuses..

RxSight, Inc. (RXST) Stock Analysis: Navigating the Challenges and Opportunities in Medical Devices

RxSight, Inc. (NASDAQ: RXST), a pioneering player in the medical devices sector, is capturing attention with its innovative Light Adjustable Lens (LAL) technology. Specializing in the..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Strategic Healthcare Solutions

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the medical devices sector, is a company that individual investors might want to keep an eye on,..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unveiling a 125% Potential Upside in Biotech

Investors looking to capitalize on the burgeoning sector of biotechnology should take a closer look at Niagen Bioscience, Inc. (NASDAQ: NAGE). With a market capitalization of..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 353% Potential Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has emerged as a compelling opportunity for investors seeking exposure in the biotechnology sector. With its focus on innovative GPCR-targeted biologic..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating a Niche in Public Health Preparedness

Emergent BioSolutions Inc. (NYSE: EBS) is carving out a distinct niche in the healthcare sector, focusing on preparedness and response solutions for public health threats. With..

Intellia Therapeutics, Inc. (NTLA): Investor Outlook on a Potential 156.64% Upside in Gene Editing Innovations

Intellia Therapeutics, Inc. (NTLA), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative approach to genome editing. Headquartered in Cambridge, Massachusetts, this..

SI-BONE, Inc. (SIBN) Investor Outlook: With a 63.55% Potential Upside, What Lies Ahead?

SI-BONE, Inc. (NASDAQ: SIBN), a leader in the medical devices industry, is catching the eye of investors with a compelling potential upside of 63.55%. This healthcare..

Celcuity Inc. (CELC) Stock Analysis: Unraveling a 4.48% Potential Upside in the Healthcare Biotech Sphere

Celcuity Inc. (CELC), a trailblazer in the biotechnology sector, is making waves with its innovative approach to targeted cancer therapies. Based in Minneapolis, Minnesota, this clinical-stage..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds